Mr. William Ying reports

BENCHMARK BOTANICS STRENGTHENS MANAGEMENT TEAM WITH APPOINTMENT OF AGRICULTURE INDUSTRY EXPERT

Benchmark Botanics Inc. has added a well-respected agriculture industry leader, Dr. Hua Zhang, to the Benchmark team as vice-president of production. Dr. Zhang will provide operational expertise overseeing overall production strategies and planning as the company continues to expand and ensure the highest-quality cannabis products are produced at its Peachland cannabis complex and the Pitt Meadows greenhouse operations.

"The addition of Hua further strengthens our team and we look forward to working with this well-known industry leader," said William Ying, chief executive officer, Benchmark Botanics. "Professionalism and quality are central to bringing the best products to market, we welcome his expertise as we continue to grow our business around the country and into international markets."

Mr. Zhang has a long and extensive history of agricultural growing and production experience. Most recently, he was head grower and director of production for Hortalizas Argaman in Jalisco, Mexico, where he oversaw the 135-acre farm including cucumber and tomato greenhouse production. Prior to Hortalizas Agraman, Mr. Zhang worked in Canada for 18 years, which included being the head grower for Amoco Farms and Enns Plant Farms. He managed year-round production planning, climate and irrigation controls, labour budgeting, developing and implementing IPM strategy, personnel training, and development. In 1997, he graduated with a PhD in horticulture from Kansas State University.

Dr. Zhang stated: "I'm excited about working with Benchmark Botanics and leading the company's production in this growing and vibrant industry. Growing is my passion and I am particularly enthralled with the cannabis industry. I'm looking forward to this opportunity to make Benchmark Botanics a world leader in the cannabis industry."

The addition of Dr. Zhang is the latest example of Benchmark Botanics' strategy for building and working with the best talent in the industry. Coupled with its licensed production facilities, a rapidly expanding international medical cannabis business and growing medical cannabis research, the company is uniquely positioned to realize the opportunity presented by the advancement of cannabis legislation in Canada and increasingly around the world.

Benchmark on Jan. 24, 2019, granted 450,000 stock options to Dr. Zhang and 600,000 stock options to James Moore, Benchmark's board of director, announced in a news release on Jan. 9, 2019. These options are exercisable at 45 cents per share expiring in five years and vesting over a two-year period in accordance with the terms of Benchmark's stock option plan and subject to regulatory approval.

About Benchmark Botanics Inc.

Benchmark Botanics is a diversified multilicensed cannabis producer focused on its three-way vertical business model targeting the medical, pharmaceutical and recreational markets in Canada and the European Union. The company's business plan includes a strategy to become a Canadian licensed producer to pioneer selling medical cannabis and hemp in China and throughout Asia.

We seek Safe Harbor.